SCHEMBL3174310

SCHEMBL3174310

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCCC(C(N)=O)C2)nc(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 7/20 0.43
▸ ADORA1 P30542 7/20 0.43
▸ LMNA P02545 2/20 0.42
▸ PIK3CA P42336 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ ADORA3 P0DMS8 5/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ MAP3K12 Q12852 1/20 0.39
▸ P2RY12 Q9H244 2/20 0.39
▸ ADORA2B P29275 1/20 0.38
▸ MAPK8 P45983 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165495 0.90 TDP1 (0.45) ADORA2AADORA1PIK3CAMTORADORA3
SCHEMBL3170604 0.89 ADORA2A (0.40) ADORA2AADORA1LMNAADORA3ALDH1A1
SCHEMBL3161848 0.89 HPGD (0.49) ADORA2AADORA1LMNAADORA3ALDH1A1
SCHEMBL3170981 0.89 HTT (0.49) ALDH1A1KDM4EP2RY12
SCHEMBL3174594 0.88 ADORA2A (0.45) ADORA2AADORA1LMNAADORA3ALDH1A1
SCHEMBL3166225 0.88 ADORA2A (0.45) ADORA2AADORA1LMNAADORA3ALDH1A1
SCHEMBL3155863 0.87 NPC1 (0.40) ADORA2AADORA1ADORA3ALDH1A1KDM4E
SCHEMBL3162937 0.87 ADORA2A (0.46) ADORA2AADORA1LMNAADORA3ALDH1A1
SCHEMBL3169774 0.83 ADORA2A (0.43) ADORA2AADORA1LMNAADORA3ALDH1A1
SCHEMBL3161815 0.83 ADORA2A (0.42) ADORA2AADORA1ADORA3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback